Home/Hedge Fund Intelligence/Immunocore Holdings plc
Nasdaq: IMCRStockForm 13F30 Jun 2026

Hedge funds that hold Immunocore Holdings plc Equity Nasdaq: IMCR

Equity · CUSIP 45258D105 · who reports it, how much, and how much it matters to them

32 of the 720 hedge fund managers we track reported shares of Immunocore Holdings plc (Nasdaq: IMCR) on Form 13F for 30 June 2026. Between them they reported USD 541m. The largest position belongs to RTW Investments, at USD 155m. The manager with the most riding on it is Kynam Capital Management, where it is 2.4% of the reported book.

Managers reporting it32of 720 we track
Value they reportUSD 541mshares only, 30 Jun 2026
Funds they run390with a file on PPLI.com
Largest positionUSD 155mRTW Investments
Typical weight0.0%median share of a manager's book
Heaviest weight2.4%Kynam Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

32 managers, USD 541m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Immunocore Holdings plc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1RTW Investments2 funds on PPLI.comUSD 155m1.3%
2Two Sigma Investments35 funds on PPLI.comUSD 52m0.0%
3Millennium Management6 funds on PPLI.comUSD 51m0.0%
4Armistice Capital1 fund on PPLI.comUSD 45m0.6%
5Kynam Capital Management1 fund on PPLI.comUSD 44m2.4%
6POINT72 Asset Management17 funds on PPLI.comUSD 31m0.0%
7Logos Global Management1 fund on PPLI.comUSD 19m0.8%
8Marshall Wace LLP84 funds on PPLI.comUSD 19m0.0%
9Hudson Bay Capital Management8 funds on PPLI.comUSD 19m0.1%
10Citadel Advisors32 funds on PPLI.comUSD 18m0.0%
11Braidwell12 funds on PPLI.comUSD 17m0.6%
12Fulcrum Asset Management LLP7 funds on PPLI.comUSD 14m1.4%
13D. E. Shaw & Co.15 funds on PPLI.comUSD 13m0.0%
14Deep Track Capital1 fund on PPLI.comUSD 9.9m0.1%
15Boothbay Fund Management2 funds on PPLI.comUSD 9.4m0.1%
16Moore Capital Management7 funds on PPLI.comUSD 8.7m0.1%
17Renaissance Technologies13 funds on PPLI.comUSD 3.3m0.0%
18Persistent Asset Partners10 funds on PPLI.comUSD 2.1m0.6%
19Engineers Gate Manager1 fund on PPLI.comUSD 1.9m0.0%
20J. Goldman & Co.1 fund on PPLI.comUSD 1.7m0.0%
21Eagle Health Investments1 fund on PPLI.comUSD 1.5m0.2%
22HighVista Strategies27 funds on PPLI.comUSD 1.4m0.3%
23Bridgewater Associates45 funds on PPLI.comUSD 1.2m0.0%
24Brevan Howard Capital Management39 funds on PPLI.comUSD 1.1m0.0%
25Entrypoint Capital1 fund on PPLI.comUSD 724,0000.2%
26Cinctive Capital Management5 funds on PPLI.comUSD 695,0000.0%
27Aquatic Capital Management3 funds on PPLI.comUSD 558,0000.0%
28Squarepoint Ops7 funds on PPLI.comUSD 373,0000.0%
29Scientech Research2 funds on PPLI.comUSD 281,0000.2%
30Wolverine Asset Management1 fund on PPLI.comUSD 89,5980.0%
31The Quarry1 fund on PPLI.comUSD 1,9690.0%
32Elequin Capital2 funds on PPLI.comUSD 320.0%
Next: where it matters most
Where it matters most

For Kynam Capital Management it is 2.4% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Kynam Capital ManagementUSD 44m2.4%
2Fulcrum Asset Management LLPUSD 14m1.4%
3RTW InvestmentsUSD 155m1.3%
4Logos Global ManagementUSD 19m0.8%
5Persistent Asset PartnersUSD 2.1m0.6%
6BraidwellUSD 17m0.6%
7Armistice CapitalUSD 45m0.6%
8HighVista StrategiesUSD 1.4m0.3%
9Eagle Health InvestmentsUSD 1.5m0.2%
10Scientech ResearchUSD 281,0000.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Immunocore Holdings plc

What is the ticker symbol of Immunocore Holdings plc?

Immunocore Holdings plc trades under the symbol IMCR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 45258D105.

Which hedge funds own Immunocore Holdings plc (Nasdaq: IMCR)?

32 of the 720 hedge fund managers PPLI.com tracks reported Immunocore Holdings plc shares on Form 13F for 30 June 2026. The largest reported positions were held by RTW Investments (USD 155m), Two Sigma Investments (USD 52m), Millennium Management (USD 51m), Armistice Capital (USD 45m) and Kynam Capital Management (USD 44m).

How many hedge funds hold Immunocore Holdings plc?

32 managers in our coverage reported it, and between them they run 390 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Immunocore Holdings plc?

Kynam Capital Management, where the position was 2.4% of the reported 13F book at 30 June 2026.

Does this show who is short Immunocore Holdings plc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Immunocore Holdings plc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.